NexGard Combo for cats: composition and precautions

NexGard Combo combines three active substances and is prescription-only. It is indicated when the parasite groups described in the SPC are involved.

A combination with a specific indication

The verified presentation contains esafoxolaner, eprinomectin and praziquantel and is intended for spot-on use in cats. The combination must not be reduced to the generic claim “against all parasites”.

The SPC defines when the combination is appropriate, which parasites it covers and which limitations apply.

Selection and application

Weight, age, clinical status, exposure and concurrent treatments must be assessed before prescribing. Packs are not interchangeable.

Onset or duration of action must not be used as universal promises: the current leaflet and veterinary assessment remain authoritative.

Sources and documentary update

Documentation updated on 24 July 2026. This article summarises the official sources or professional guidance listed on the page and does not replace diagnosis, prescribing or instructions from a veterinarian. For any medicine, the summary of product characteristics or package leaflet for the specific presentation remains authoritative.

• UPD — NexGard Combo spot-on (accessed 24 July 2026)

Editorial transparency: sources are listed so that the documentation can be checked. Professional review is stated only after genuine approval by a qualified, identifiable person.